These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 37144735)

  • 21. The prognostic value of a reverse transcriptase-PCR assay of sentinel lymph node biopsy for patients with cutaneous melanoma: a single-center analysis in Japan.
    Ito T; Moroi Y; Oba J; Nakahara T; Takeuchi S; Uchi H; Takahara M; Masuda T; Furue M
    Melanoma Res; 2012 Feb; 22(1):38-44. PubMed ID: 22108607
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Sentinel lymph node status as most important prognostic factor in patients with high-risk cutaneous melanomas (tumour thickness >4.00 mm): outcome analysis from a single institution.
    Hinz T; Ahmadzadehfar H; Wierzbicki A; Hoeller T; Wenzel J; Biersack HJ; Bieber T; Schmid-Wendtner MH
    Eur J Nucl Med Mol Imaging; 2012 Aug; 39(8):1316-25. PubMed ID: 22618833
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Sentinel node biopsy for melanoma: an update after two decades of experience.
    Ross MI
    Semin Cutan Med Surg; 2010 Dec; 29(4):238-48. PubMed ID: 21277537
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Prognostic Gene Expression Profiling in Cutaneous Melanoma: Identifying the Knowledge Gaps and Assessing the Clinical Benefit.
    Grossman D; Okwundu N; Bartlett EK; Marchetti MA; Othus M; Coit DG; Hartman RI; Leachman SA; Berry EG; Korde L; Lee SJ; Bar-Eli M; Berwick M; Bowles T; Buchbinder EI; Burton EM; Chu EY; Curiel-Lewandrowski C; Curtis JA; Daud A; Deacon DC; Ferris LK; Gershenwald JE; Grossmann KF; Hu-Lieskovan S; Hyngstrom J; Jeter JM; Judson-Torres RL; Kendra KL; Kim CC; Kirkwood JM; Lawson DH; Leming PD; Long GV; Marghoob AA; Mehnert JM; Ming ME; Nelson KC; Polsky D; Scolyer RA; Smith EA; Sondak VK; Stark MS; Stein JA; Thompson JA; Thompson JF; Venna SS; Wei ML; Swetter SM
    JAMA Dermatol; 2020 Sep; 156(9):1004-1011. PubMed ID: 32725204
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Gene expression profiling for molecular staging of cutaneous melanoma in patients undergoing sentinel lymph node biopsy.
    Gerami P; Cook RW; Russell MC; Wilkinson J; Amaria RN; Gonzalez R; Lyle S; Jackson GL; Greisinger AJ; Johnson CE; Oelschlager KM; Stone JF; Maetzold DJ; Ferris LK; Wayne JD; Cooper C; Obregon R; Delman KA; Lawson D
    J Am Acad Dermatol; 2015 May; 72(5):780-5.e3. PubMed ID: 25748297
    [TBL] [Abstract][Full Text] [Related]  

  • 26.
    Li N; Zhou X; Zhu H; Wang F; Guo R; Zhang Y; Song Y; Zhai S; Xie Q; Liu J; Li Z; Yang Z
    Ann Nucl Med; 2023 Mar; 37(3):189-197. PubMed ID: 36586034
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Sentinel lymph node biopsy in cutaneous melanoma of the head and neck using the indocyanine green SPY Elite system.
    Vahabzadeh-Hagh AM; Blackwell KE; Abemayor E; St John MA
    Am J Otolaryngol; 2018; 39(5):485-488. PubMed ID: 29803536
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Sentinel lymph node biopsy for cutaneous melanoma: results of 10 years' experience in two regional training hospitals in the Netherlands.
    van den Broek FJ; Sloots PC; de Waard JW; Roumen RM
    Int J Clin Oncol; 2013 Jun; 18(3):428-34. PubMed ID: 22402887
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Molecular markers to complement sentinel node status in predicting survival in patients with high-risk locally invasive melanoma.
    Rowe CJ; Tang F; Hughes MC; Rodero MP; Malt M; Lambie D; Barbour A; Hayward NK; Smithers BM; Green AC; Khosrotehrani K
    Int J Cancer; 2016 Aug; 139(3):664-72. PubMed ID: 26990817
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Sentinel Lymph Node Biopsy in Thick-Melanoma Patients (N=350): What is Its Prognostic Role?
    Ribero S; Osella-Abate S; Sanlorenzo M; Balagna E; Senetta R; Fierro MT; Macripò G; Macrì L; Sapino A; Quaglino P
    Ann Surg Oncol; 2015; 22(6):1967-73. PubMed ID: 25388059
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Sentinel Lymph Node Biopsy in T4 Melanoma: An Important Risk-Stratification Tool.
    Gyorki DE; Sanelli A; Herschtal A; Lazarakis S; McArthur GA; Speakman D; Spillane J; Henderson MA
    Ann Surg Oncol; 2016 Feb; 23(2):579-84. PubMed ID: 26471491
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Prognostic usefulness of sentinel lymph node biopsy for patients who have clinically node negative, localized, primary invasive cutaneous melanoma: a Bayesian analysis using informative published reports.
    Rhodes AR
    Arch Dermatol; 2011 Apr; 147(4):408-15. PubMed ID: 21173300
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Sentinel Lymph Node Biopsy for Recurrent Melanoma: A Multicenter Study.
    Beasley GM; Hu Y; Youngwirth L; Scheri RP; Salama AK; Rossfeld K; Gardezi S; Agnese DM; Howard JH; Tyler DS; Slingluff CL; Terando AM
    Ann Surg Oncol; 2017 Sep; 24(9):2728-2733. PubMed ID: 28508145
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The intriguing effect of delay time to sentinel lymph node biopsy on survival: a propensity score matching study on a cohort of melanoma patients.
    Tejera-Vaquerizo A; Descalzo-Gallego MA; Traves V; Requena C; Bolumar I; Pla A; Nagore E
    Eur J Dermatol; 2017 Oct; 27(5):487-495. PubMed ID: 28944755
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Is it Necessary to Perform Sentinel Lymph Node Biopsy in Thin Melanoma? A Retrospective Single Center Analysis.
    Kocsis A; Karsko L; Kurgyis Z; Besenyi Z; Pavics L; Dosa-Racz E; Kis E; Baltas E; Ocsai H; Varga E; Bende B; Varga A; Mohos G; Korom I; Varga J; Kemeny L; Nemeth IB; Olah J
    Pathol Oncol Res; 2020 Jul; 26(3):1861-1868. PubMed ID: 31792874
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Tumour thickness as a predictor of occult lymph node metastases in patients with stage I and II melanoma undergoing sentinel lymph node biopsy.
    Lens MB; Dawes M; Newton-Bishop JA; Goodacre T
    Br J Surg; 2002 Oct; 89(10):1223-7. PubMed ID: 12296887
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Sentinel lymph node biopsy in malignant melanoma of the head and neck.
    Rahimi-Nedjat RK; Al-Nawas B; Tuettenberg A; Sagheb K; Grabbe S; Walter C
    J Craniomaxillofac Surg; 2018 Jun; 46(6):1027-1031. PubMed ID: 29735384
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Prognostic factors for Taiwanese patients with cutaneous melanoma undergoing sentinel lymph node biopsy.
    Wu CE; Hsieh CH; Chang CJ; Yeh JT; Kuo TT; Yang CH; Lo YF; Lin KJ; Lin YC; Chang JW
    J Formos Med Assoc; 2015 May; 114(5):415-21. PubMed ID: 23969039
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Single-institution experience in the management of patients with clinical stage I and II cutaneous melanoma: results of sentinel lymph node biopsy in 240 cases.
    Rex J; Paradelo C; Mangas C; Hilari JM; Fernández-Figueras MT; Fraile M; Alastrué A; Ferrándiz C
    Dermatol Surg; 2005 Nov; 31(11 Pt 1):1385-93. PubMed ID: 16416605
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Sentinel lymph node biopsy in patients with thin primary cutaneous melanoma.
    Murali R; Haydu LE; Quinn MJ; Saw RP; Shannon K; Spillane AJ; Stretch JR; Thompson JF; Scolyer RA
    Ann Surg; 2012 Jan; 255(1):128-33. PubMed ID: 21975320
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.